Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation (NYSE: ITGR) is a medical device contract development and manufacturing organization (CDMO) that regularly issues news on its operations, financial performance, and corporate developments. The company focuses on serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets, and its updates reflect activity across these areas.
On this page, readers can follow ITGR news related to quarterly earnings, product line performance, and outlooks that Integer provides through press releases furnished with Form 8-K filings. These releases often include discussions of sales trends in Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets, along with non-GAAP financial measures such as adjusted operating income, adjusted EBITDA, adjusted net income, and adjusted earnings per share.
Integer’s news flow also covers strategic and governance events, such as leadership transitions, board appointments, and capital allocation decisions. Recent examples include the appointment of a new President and Chief Executive Officer, the election of a new director with extensive medical device industry experience, and the authorization of a share repurchase program by the Board of Directors.
In addition, Integer publishes updates on technology and market-facing activities, such as participation in medical society meetings and healthcare investor conferences. The company has highlighted innovations in neuromodulation and miniaturized active implantable medical devices, including high-performance batteries and integrated implantable pulse generator and lead systems, as well as its Xcellion Gen 3 fast charge lithium ion battery technology.
Investors and observers can use this news page to monitor how Integer communicates its strategy, product line dynamics, financing actions, and role as a CDMO in the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
Integer Holdings Corporation (NYSE: ITGR) has opened a new Galway Research and Development (R&D) Innovation Centre in Ireland. This 8,500 square foot facility will enhance Integer's ability to develop high-quality medical devices, particularly in the cardio and vascular sectors. With increased lab space and collaborative environments, the center will support innovation and growth for Integer and its customers. The Galway facility complements existing operations and aims to strengthen Integer's position within the global medical device sector.
Integer Holdings Corporation (NYSE:ITGR) announced its financial results for Q1 2020, reporting a 45% increase in GAAP EPS and a 26% rise in adjusted income. Total sales grew 4% to $328 million. Despite challenges from COVID-19, sales were largely unaffected, particularly in Cardio & Vascular, which rose 17%. However, the company suspended its annual guidance due to uncertainties surrounding the pandemic. A total debt reduction to $804 million was noted, achieving a leverage ratio of 2.8 times adjusted EBITDA.